Quantcast

Latest gout Stories

2010-11-09 06:00:00

SAN DIEGO, Nov. 9, 2010 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA), a biotechnology company focused on the development of small-molecule therapeutics for the treatment of serious diseases, today reported recent accomplishments and financial results for the three and nine months ended September 30, 2010. "Recent data from two clinical studies demonstrate that the combination of RDEA594 with either of the currently marketed drugs for gout, febuxostat...

2010-11-08 19:44:19

Allopurinol, a relatively inexpensive anti-gout medication that has been on the market for more than 20 years, may have some activity against colorectal adenomas, according to data presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, held here Nov. 7-10, 2010. Specifically, the presence of a colorectal tumor tissue biomarker, Ki67, was markedly decreased in the preliminary results of a study of patients with colorectal polyps assigned to take allopurinol....

2010-11-08 09:38:00

ATLANTA, Nov. 8, 2010 /PRNewswire/ -- Patients who experience gout flares can be treated safely with Colcrys® (colchicine, USP), even in the presence of co-morbid conditions that often present physicians with treatment challenges, according to a new analysis presented here at the 74th Annual Scientific Meeting of the American College of Rheumatology (ACR). "Many patients with gout have other serious health conditions to consider, including cardiovascular and metabolic...

2010-11-08 06:00:00

SAN DIEGO, Nov. 8, 2010 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA) today announced positive results from two clinical studies of RDEA594 in combination with currently marketed drugs for the treatment of gout patients, febuxostat (Uloric®) and allopurinol. RDEA594, Ardea's lead product candidate for the chronic management of hyperuricemia and gout, is an orally administered compound that inhibits the URAT1 transporter, a biological mechanism that...

2010-11-05 07:00:00

CAMBRIDGE, Mass., Nov. 5, 2010 /PRNewswire/ -- Sermo (http://www.sermo.com), the world's largest online community for physicians, today announced a free Sermo Report titled, "Treatment Options for Gout". The report gathered feedback from physicians to better understand how they currently treat gout and if they would consider using new treatments. While many physicians who participated felt that current gout treatments effectively manage acute and suppressed gout flares, 63% confirmed...

2010-11-03 11:50:00

CHICAGO, Nov. 3, 2010 /PRNewswire/ --Don't let sore, achy feet ruin your holiday season. The American College of Foot and Ankle Surgeons offers five tips to healthy holiday feet. 1. If the shoe fits, wear it--When hitting the dance floor or the shopping malls during the holiday season, don't compromise comfort and safety when picking the right shoes to wear. Narrow shoes, overly-high-heeled ones or shoes that aren't worn very often, such as dress shoes, can irritate feet and lead to...

d3d447817df246504204ce301e7fe0061
2010-10-27 14:15:00

A new study has found that regular consumption of soda and other sugar-sweetened beverages is associated with a clear and consistently greater risk of metabolic syndrome and type 2 diabetes. According to the Harvard School of Public Health (HSPH) researchers, the study provides empirical evidence that intake of sugary beverages should be limited to reduce risk of these conditions. The study appears online October 27, 2010, in the journal Diabetes Care and will appear in the November print...

2010-10-14 07:00:00

EXTON, Pa., Oct. 14 /PRNewswire/ -- BioTrends Research Group, Inc. is pleased to announce the recent release of a syndicated report focused on the management and treatment of gout in the US. ChartTrends®: Gout is an annual publication based on patient and laboratory data collected from over 1,000 gout patient charts. It provides insight into the factors that drive decisions to treat, brand selection of uric acid lowering (UAL) therapies, patient characterizations and...

2010-09-30 13:48:00

Drug commonly used to prevent gout, treat gout flares, and treat Familial Mediterranean Fever (FMF) SILVER SPRING, Md., Sept. 30 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today took action against companies that manufacture, distribute, and/or market unapproved single-ingredient oral colchicine, a medication commonly used for the daily prevention of gout, to treat acute gout flare-ups, and for the treatment of Familial Mediterranean Fever (FMF). (Logo:...

2010-09-14 17:09:00

EAST BRUNSWICK, N.J., Sept. 14 /PRNewswire-FirstCall/ -- Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) today announced that the U.S. Food and Drug Administration (FDA) has approved KRYSTEXXA(TM) (pegloticase), a PEGylated uric acid specific enzyme indicated for the treatment of chronic gout in adult patients refractory to conventional therapy. Chronic gout that is refractory to conventional therapy occurs in patients who have failed to normalize serum uric acid and whose signs and...


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related